Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL BGK 2 3 5 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL BGK 2 3 5 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 IN PLASTIC CONTAINER.
PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER vs PRISMASOL BK 0/0 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol BGK 2/3.5 is a sterile, non-pyrogenic hemofiltration solution used in continuous renal replacement therapy (CRRT). It does not have a pharmacological mechanism of action; rather, it provides electrolyte composition (sodium, potassium, calcium, magnesium, chloride, lactate) and glucose to replace fluid and electrolyte losses during hemofiltration or hemodialysis, maintaining acid-base balance and electrolyte homeostasis. The lactate in the solution serves as a bicarbonate precursor, metabolized to bicarbonate by the liver, helping to correct metabolic acidosis.
Prismasol BK 0/0 is a sterile, nonpyrogenic bicarbonate-buffered replacement solution for continuous renal replacement therapy (CRRT). It acts as an electrolyte and buffer replacement to correct acid-base disturbances and maintain fluid balance during hemofiltration, with no pharmacologic active drug component.
PRISMASOL BGK 2/3.5 is a hemofiltration solution for continuous renal replacement therapy (CRRT). Administered intravenously via CRRT circuit. Typical adult dose: 1000-2000 mL/hour infusion rate adjusted to achieve effluent rate of 20-35 mL/kg/hour.
Administered as a continuous infusion at rates typically between 1000-4000 mL/hour depending on the desired effluent flow rate, patient fluid balance, and metabolic requirements. The solution is used as dialysate (hemodiafiltration) or replacement fluid (hemofiltration). Must be prescribed and administered under physician supervision using intravenous infusion via a dialyzer or hemofilter.
None Documented
None Documented
Not applicable as a single terminal half-life; components are endogenous substances with rapid turnover (e.g., lactate t1/2 ~10-20 min, electrolytes adjust within minutes to hours).
Not applicable; PRISMASOL is a dialysate solution, not a drug with systemic absorption; components are removed by dialysis.
The components are primarily excreted renally: sodium, potassium, and glucose are eliminated via urine; bicarbonate is consumed or excreted as CO2; lactate is metabolized to bicarbonate. ~100% renal for electrolytes.
Renal (80-100% in urine as unabsorbed, not metabolized); minimal biliary/fecal.
Category C
Category C
Dialysis Solution
Dialysis Solution